IL5 and allergic asthma: Overall, the results of immune profile analysis showed that PGT treatment reduced the populations of IL-5 and IL-13 producing immune cells, such as CD4+ T cells and ILCs, as well as the total amount of IL-5 and IL-13 producing cells in OVA-induced allergic asthma.